Ozempic and other weight-loss drugs will power the anti-obesity market to 16-fold gains by 2030, Goldman Sachs says

[ad_1] The anti-obesity market could become a $100 billion industry by 2030, Goldman Sachs predicts. The field is “still in its early stages” but may have reached an inflection point,…